Safety and Effectiveness of BOTOX for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
Phase of Trial: Phase IV
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Facial-wrinkles
- Focus Adverse reactions
- Sponsors Allergan
- 27 Oct 2017 Status changed from recruiting to completed.
- 23 Jun 2015 Planned End Date changed from 1 Feb 2018 to 1 Nov 2017 as per ClinicalTrials.gov record.
- 23 Jun 2015 Planned primary completion date changed from 1 Feb 2018 to 1 Nov 2017 as per ClinicalTrials.gov record.